Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $104.57 in the prior trading day, Spruce Biosciences Inc (NASDAQ: SPRB) closed at $110.0, up 5.19%. In other words, the price has increased by $5.19 from its previous closing price. On the day, 54254.0 shares were traded. SPRB stock price reached its highest trading level at $110.0 during the session, while it also had its lowest trading level at $105.0.
Ratios:
Our goal is to gain a better understanding of SPRB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.54 and its Current Ratio is at 1.54. In the meantime, Its Debt-to-Equity ratio is 0.25 whereas as Long-Term Debt/Eq ratio is at 0.09.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 06 ’25 when Parkman Healthcare Partners LL bought 256 shares for $17.91 per share. The transaction valued at 4,585 led to the insider holds 1,307 shares of the business.
Parkman Healthcare Partners LL sold 257 shares of SPRB for $4,920 on Oct 06 ’25. The 10% Owner now owns 1,050 shares after completing the transaction at $19.14 per share. On Oct 06 ’25, another insider, Parkman Healthcare Partners LL, who serves as the 10% Owner of the company, bought 256 shares for $17.91 each. As a result, the insider paid 4,585 and bolstered with 1,307 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRB now has a Market Capitalization of 117740704 and an Enterprise Value of 108419696. For the stock, the TTM Price-to-Sale (P/S) ratio is 168.20 while its Price-to-Book (P/B) ratio in mrq is 11.51. Its current Enterprise Value per Revenue stands at 155.552 whereas that against EBITDA is -2.192.
Stock Price History:
The Beta on a monthly basis for SPRB is 3.52, which has changed by -0.9660142 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, SPRB has reached a high of $240.00, while it has fallen to a 52-week low of $4.28. The 50-Day Moving Average of the stock is 10.25%, while the 200-Day Moving Average is calculated to be 220.83%.
Shares Statistics:
The stock has traded on average 533.64K shares per day over the past 3-months and 207740 shares per day over the last 10 days, according to various share statistics. A total of 1.07M shares are outstanding, with a floating share count of 1.07M. Insiders hold about 0.00% of the company’s shares, while institutions hold 33.76% stake in the company. Shares short for SPRB as of 1763078400 were 86921 with a Short Ratio of 0.16, compared to 1760486400 on 20500. Therefore, it implies a Short% of Shares Outstanding of 86921 and a Short% of Float of 8.1999995.
Earnings Estimates
Spruce Biosciences Inc (SPRB) is presently subject to a detailed evaluation by 1.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$6.72, with high estimates of -$6.72 and low estimates of -$6.72.
Analysts are recommending an EPS of between -$23.84 and -$23.84 for the fiscal current year, implying an average EPS of -$23.84. EPS for the following year is -$28.18, with 1.0 analysts recommending between -$28.18 and -$28.18.
